期刊文献+

原位减体积肝移植治疗小儿先天性代谢紊乱临床疗效观察 被引量:7

Clinical observation of orthotopic liver transplantation in the treatment of children with congenital metabolic diseases
原文传递
导出
摘要 目的 探讨肝移植治疗小儿先天性代谢紊乱的临床疗效。方法 采用同种异体背驮式原位减体积肝移植术及术后控制感染 ,免疫抑制 ,营养支持 ,监测各项临床及血生化指标等综合方法 ,治疗鸟氨酸甲酰基转移酶缺乏症 (OTCD)、糖原累积病Ⅰ型各 1例。结果 OTCD患儿术后 6个月 ,正常蛋白饮食 ,各项化验指标正常 ,生长发育和智能发育正常 ,FK5 0 6血药浓度维持在有效水平 ;糖原累积病Ⅰ型患儿术后 15个月 ,正常饮食 ,各项化验指标正常 ,体重增加 7kg ,身高增长 19cm ,FK5 0 6血药浓度维持在 6 7~ 8 4 μg/L。 结论 肝移植不失为小儿先天性代谢紊乱的一种有效的治疗方法。 Objective To explore the efficacy of liver transplantation in the treatment of children with congenital metabolic disorder.Methods Two 4~8 years children with congenital metabolic disorder (case 1 was ornithine transcarbamylase deficiency-OTCD,case 2 glycogen storage disease typeⅠ) were treated with orthotopic liver transplantation and comprehensive therapy including infection control,immunosuppression,nutritional supporting,clinical and biochemical monitoring.Results It took 6 months for case 1 and 15 months for case 2 to become normal in diet,serum ammonia,glucose,lactic acid,growth and intelligence after surgery.Case 2 increased 7kg in weight,19cm in height,maintained his FK506 concentration at 6 7~8 4 ng/mL.Conclusion Liver transplantation has been proven to be a safe and effective therapy in children with congenital metabolic disorder.
出处 《中国实用儿科杂志》 CSCD 北大核心 2002年第7期398-399,共2页 Chinese Journal of Practical Pediatrics
  • 相关文献

参考文献1

同被引文献118

  • 1简忠,冯莉莉,李颖利,谭伟,陈旭岩.先天性高氨血症一例报告[J].中国急救复苏与灾害医学杂志,2007,2(5):299-300. 被引量:2
  • 2杨艳玲,孙芳,钱宁,宋金青,王爽,常杏芝,杨宏云,王淑琴,李龙,张月华,包新华,李明,戚豫,秦炯,吴希如.尿素循环障碍的临床和实验室筛查研究[J].中华儿科杂志,2005,43(5):331-334. 被引量:36
  • 3周平,宋元宗,肖昕,柳国胜.鸟氨酸氨甲酰基转移酶缺陷病1例[J].实用儿科临床杂志,2006,21(8):459-459. 被引量:10
  • 4宋元宗,郝虎,柳国胜,肖昕,王自能.鸟氨酸氨甲酰基转移酶缺陷症尿液标志物的气相色谱-质谱法分析[J].基础医学与临床,2007,27(7):811-814. 被引量:5
  • 5Kayler LK, Merion RM, Lee S, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant, 2002, 6: 295-300.
  • 6Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.Science, 2002, 296: 2410-2413.
  • 7Cabrera-Salazar MA, Novelli E, Barranger JA. Gene therapy for the lysosomal storage disorders. Curt Opin Mol Ther, 2002, 4:349-358.
  • 8Ding EY, Hodges BL, Hu H, et al. Long-term efficacy after [El-,polymerase-] adenovirus-medlated trander of htlman acid-alpha-glucosidase gene into glycogen storage disease type Ⅱ knockout mice.Hum Gene Ther, 2001, 12: 955-965.
  • 9Lyon G, Adams RD, Koiodny EH. eds. Neurology of hereditary metabolic disease of children. 2nd ed. New York: McGraw-Hill,1996.352-363.
  • 10Scriver CR, Beaudet AL, Sly WS, et al. eds. The metabolic and molecular bases of inherited diseases. 8th ed. New York : McGraw-Hill, 2001.1-100.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部